Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-02-21

Clinical Trial Update: Avelumab in Combination With Fluorouracil and Mitomycin or Cisplatin and Radiation Therapy in Treating Participants With Muscle-Invasive Bladder Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating avelumab with fluorouracil and mitomycin or with cisplatin and radiation therapy for muscle-invasive bladder cancer has completed with …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Avelumab (avelumab)
  • CISPLATIN (cisplatin)
  • FLUOROURACIL (Fluorouracil)
  • Mitomycin (Mitomycin)
  • Radiation therapy

Snippet

Sponsor: Mayo Clinic | Conditions: Bladder Carcinoma Infiltrating the Muscle of the Bladder Wall, Stage II Bladder Cancer AJCC v8 | Phase 2 | Status: COMPLETED | Results posted: 2021-02-21